Investors eyed risks around a high-stakes US-Ukraine meeting, kicking off a week dominated by a Federal Reserve speech that ...

Palantir stock hits new highs after strong Q2 performance, but analysts warn of a potential bubble. Click here to find out ...

This high-performing stock has returned over 14,000% over its lifetime and outperformed the S&P 500 over the past one, three, five, and 10 years.

The U.S. chipmaker has struggled to keep pace in the AI market alongside competitors like Nvidia. Softbank has agreed to buy ...

Oscar Health is deeply undervalued but faces high short-term uncertainty due to ACA-specific risks. Read why I rate OSCR ...

The string of negative updates from Novo Nordisk and positive news flow from the main competitor Eli Lilly has finally ended ...

EHI offers a high yield and global diversification. But learn why investors need to watch for declining coverage and junk ...

Novo Nordisk A/S gains momentum with FDA approval for Wegovy and strategic pricing. Click for why Novo outshines Eli Lilly ...

Bank of America today announced plans to host an Investor Day on Wednesday, November 5, 2025, in Boston, with presentations by the company's Management Team.

Wall Street ticked modestly lower ahead of U.S. President Donald Trump’s meeting with Ukrainian President Volodymyr Zelenskyy ...

Narendra Modi's administration revealed plans over the weekend for the largest tax overhaul since 2017, with consumer, auto ...

Understand the risks of investing in BOIL, a 2x leveraged natural gas ETF. Learn why it's suited for active traders, not long ...